Scientists test re-engineered immune cells to fight tough cancers
NCT ID NCT06237881
Summary
This early-stage study is testing a new personalized cell therapy called KSQ-001EX in people with advanced melanoma, lung cancer, or head and neck cancer. Doctors take a patient's own immune cells from a tumor, genetically modify them to potentially be more powerful, and then infuse them back into the patient. The main goals are to see if this treatment is safe and to look for early signs that it can shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.